Regulatory Updates
Sep 12, 2026•1 min read
FDA Approves ANDA216216 for METOLAZONE Tablets
The FDA has approved application ANDA216216 for METOLAZONE oral tablets in 2.5 mg, 5 mg, and 10 mg strengths, sponsored by NE RX Pharma.
Regulatory Updates
Aug 31, 2026•1 min read
FDA Approves ANDA078249 for Torsemide Tablets by Aurobindo Pharma
The FDA has approved application ANDA078249 for torsemide oral tablets, manufactured by Aurobindo Pharma and Rising Pharma Holdings, covering strengths from 5 mg to 100 mg.